scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1034789356 |
P356 | DOI | 10.1038/SJ.JHH.1001812 |
P698 | PubMed publication ID | 15647778 |
P5875 | ResearchGate publication ID | 8083186 |
P50 | author | Coenraad Dirk Adriaan Stehouwer | Q68596151 |
Casper G. Schalkwijk | Q76998834 | ||
P2093 | author name string | J W R Twisk | |
M T Schram | |||
R G Ijzerman | |||
F J van Ittersum | |||
R A J M van Dijk | |||
A Spoelstra-de Man | |||
P2860 | cites work | Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators | Q28144781 |
Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes | Q28188162 | ||
The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes | Q28188182 | ||
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure<SUBTITLE>The JNC 7 Report</SUBTITLE> | Q28204197 | ||
Longitudinal data analysis for discrete and continuous outcomes | Q29547235 | ||
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy | Q29615215 | ||
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women | Q29616306 | ||
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group | Q29617736 | ||
Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials | Q33897188 | ||
Effects of antihypertensive drugs on vascular remodeling: do they predict outcome in response to antihypertensive therapy? | Q34331686 | ||
Effect of losartan in aging-related endothelial impairment | Q43897720 | ||
Effects of eprosartan versus hydrochlorothiazide on markers of vascular oxidation and inflammation and blood pressure (renin-angiotensin system antagonists, oxidation, and inflammation). | Q43919591 | ||
Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death | Q43935480 | ||
Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1. | Q44083504 | ||
Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64). | Q44242786 | ||
The effect of nisoldipine as compared with enalapril on cardiovascular outcomes in patients with non-insulin-dependent diabetes and hypertension | Q44611131 | ||
Left ventricular mass increases with deteriorating glucose tolerance, especially in women: independence of increased arterial stiffness or decreased flow-mediated dilation: the Hoorn study | Q44745068 | ||
Endothelium-dependent and -independent vasodilation of large arteries in normoalbuminuric insulin-dependent diabetes mellitus. | Q50985397 | ||
Outcome results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in patients with hypertension and NIDDM. | Q51570195 | ||
von Willebrand Factor, C-Reactive Protein, and 5-Year Mortality in Diabetic and Nondiabetic Subjects | Q57830297 | ||
Fosinopril decreases levels of soluble vascular cell adhesion molecule-1 in borderline hypertensive type II diabetic patients with microalbuminuria | Q74631559 | ||
Plasma concentration of C-reactive protein is increased in type I diabetic patients without clinical macroangiopathy and correlates with markers of endothelial dysfunction: evidence for chronic inflammation | Q74651672 | ||
P433 | issue | 6 | |
P921 | main subject | endothelium | Q111140 |
hydrochlorothiazide | Q423930 | ||
P304 | page(s) | 429-437 | |
P577 | publication date | 2005-06-01 | |
P1433 | published in | Journal of Human Hypertension | Q15746469 |
P1476 | title | Aggressive antihypertensive therapy based on hydrochlorothiazide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: effects on albumin excretion, endothelial function and inflammation in a double-blind, random | |
P478 | volume | 19 |